Evidence map›Paper›PMID 29414782›Full record

ArticleThe Journal of biological chemistry2018

B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2's apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors.

Karl L Banta, Xinyue Wang, Phani Das, Astar Winoto

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. International journal of molecular sciences · 2025
    Article
  4. Controversy and multiple roles of the solitary nucleus receptor Nur77 in disease and physiology.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Karl L BantaDepartment of Molecular and Cell Biology and Cancer Research Laboratory, University of California, Berkeley, California 94720-3200.
Xinyue WangDepartment of Molecular and Cell Biology and Cancer Research Laboratory, University of California, Berkeley, California 94720-3200.
Phani DasDepartment of Molecular and Cell Biology and Cancer Research Laboratory, University of California, Berkeley, California 94720-3200.
Astar WinotoDepartment of Molecular and Cell Biology and Cancer Research Laboratory, University of California, Berkeley, California 94720-3200. Electronic address: winoto@berkeley.edu.
University of California, Berkeley · US

Funding

PROGRAMMED CELL DEATH IN NORMAL AND MALIGNANT T CELLSR01CA066236 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI WINOTO, ASTAR · 1995 to 2014
$4.7M
NCI NIH HHS R01 CA066236
6 · The paper itself

Abstract

Apoptosis is mediated through the extrinsic or intrinsic pathway. Key regulators of the intrinsic apoptotic pathway are the family of B cell lymphoma 2 (Bcl-2) proteins. The activity of the prototypical Bcl-2 protein is usually considered antiapoptotic. However, under some conditions, Bcl-2 associates with the orphan nuclear hormone receptors Nur77 and Nor-1, converting Bcl-2 into a proapoptotic molecule. Expression of Nur77 and Nor-1 is induced by a variety of signals, including those leading to apoptosis. Translocation of Nur77/Nor-1 to mitochondria results in their association with Bcl-2, exposing the Bcl-2 homology (BH) 3 domain and causing apoptosis. However, the molecular details of this interaction are incompletely understood. Here, through extensive Bcl-2 mutagenesis and functional assays, we identified residues within Bcl-2 that are essential for its interaction with Nur77/Nor-1. Although an initial report has suggested that an unstructured loop region between the Bcl-2 BH4 and BH3 domains is required for Bcl-2's interaction with Nur77/Nor-1, we found that it is dispensable for this interaction. Instead, we found important interacting residues at the BH4 domain and crucial interacting residues between the BH1 and BH2 domains. Bcl-2 alanine mutants at this region could no longer interact with Nur77/Nor-1 and could not initiate Nur77/Bcl-2-mediated cell death. However, they still retained their anti-apoptotic capability in two different death assays. These results establish crucial residues in Bcl-2 required for Nur77/Nor-1-mediated apoptosis and point to potential new strategies for manipulating Bcl-2 function.

Indexed as

ApoptosisAmino Acid SubstitutionAnimalsDNA-Binding ProteinsHEK293 CellsHeLa CellsHumansMiceMutation, MissenseNerve Tissue ProteinsNuclear Receptor Subfamily 4, Group A, Member 1Protein DomainsProto-Oncogene Proteins c-bcl-2Receptors, SteroidReceptors, Thyroid HormoneBcl2 protein, mouseDNA-Binding ProteinsNerve Tissue ProteinsNr4a1 protein, mouseNr4a3 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 1Proto-Oncogene Proteins c-bcl-2Receptors, SteroidReceptors, Thyroid Hormoneapoptosisapoptosis regulatorB-cell lymphoma 2 (Bcl-2) familyBcl-bmitochondrial apoptosisNor-1Nur77protein-protein interactionsteroid hormone receptor

Identifiers

PMID29414782
PMCPMC5880130
OpenAlexW2787819575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.